First in class
Therapeutic Pipeline
Noci Biotech LLC
is a life sciences R&D company developing regenerative prodrugs for chronic diseases
Using AI Mapping
for Chronic Diseases
Optimizing Curative Outcomes
10
Categories
32
Chronic
Diseases
18
Candidates
NociBio uses AI-based systems mapping to identify dominant dysregulated signaling hubs in chronic disease
Targeted multi-pathway modulation, optimized by chronobiology and enhanced delivery systems, aims to restore regulatory balance and improve therapeutic outcomes
Pioneering precision targeted therapeutics via the Enteric Nervous System
First-in-class
bioactive prodrugs
Multi-target inhibition
to restore cellular balance
High degree
of safety
Achieve positive,
curative outcomes